Singapore markets close in 1 hour 32 minutes

Lifeist Wellness Inc (M5B.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.02000.0000 (0.00%)
As of 08:45AM CEST. Market open.
Full screen
Previous close0.0200
Open0.0010
Bid0.0010 x N/A
Ask0.0080 x N/A
Day's range0.0010 - 0.0200
52-week range0.0010 - 0.4700
Volume0
Avg. volume97
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date30 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Lifeist Sells Australian Vapes

    Lifeist Sells Non-Core Subsidiary to Sharpen its Strategic Focus on Nutraceuticals and B2B Recreational CannabisTORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. (“Aussie Vapes”), its wholly owned Australian su

  • GlobeNewswire

    Lifeist Announces TSXV Approval of Common Share Consolidation

    TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that, further to its news release dated April 30, 2024, the TSX Venture Exchange (the "Exchange") has approved the consolidation of the Company’s issued and outstanding common shares on the basis of one (1

  • GlobeNewswire

    Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0

    Mikra partners with global leader in NutraBiosciences® to release CELLF 2.0 featuring improved flavor and consistency thanks to Virun’s patented technology TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra